The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults—An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses
Open accessAbstract
A systematic literature review and meta-analyses (where appropriate) were performed to update the previous AASM practice parameters on the treatments, both dopaminergic and other, of RLS and PLMD. A considerable amount of literature has been published since these previous reviews were performed, necessitating an update of the corresponding practice parameters. Therapies with a STANDARD level of recommendation include pramipexole and ropinirole. Therapies with a GUIDELINE level of recommendation include levodopa with dopa decarboxylase inhibitor, opioids, gabapentin enacarbil, and cabergoline (which has additional caveats for use). Therapies with an OPTION level of recommendation include carbamazepine, gabapentin, pregabalin, clonidine, and for patients with low ferritin levels, iron supplementation. The committee recommends a STANDARD AGAINST the use of pergolide because of the risks of heart valve damage. Therapies for RLS secondary to ESRD, neuropathy, and superficial venous insufficiency are discussed. Lastly, therapies for PLMD are reviewed. However, it should be mentioned that because PLMD therapy typically mimics RLS therapy, the primary focus of this review is therapy for idiopathic RLS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology
Allen, R. P., Picchietti, D., Hening, W. A., Trenkwalder, C., Walters, A. S., & Montplaisi, J. (2003) · Sleep Medicine · doi:10.1016/s1389-9457(03)00010-8 · Cited by 2,900
(2003) · Sleep Medicine · doi:10.1016/s1389-9457(02)00258-7 · Cited by 1,682
Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease
Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054830 · Cited by 884
Schünemann, H. J., Jaeschke, R., Cook, D. J., Bria, W. F., El-Solh, A. A., Ernst, A., Fahy, B. F., Gould, M. K., Horan, K. L., Krishnan, J. A., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-197st · Cited by 577
Bax, L., Yu, L.-M., Ikeda, N., Tsuruta, H., & Moons, K. G. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-50 · Cited by 514
Zaza, S., Wright-De Agüero, L. K., Briss, P. A., Truman, B. I., Hopkins, D. P., Hennessy, M. H., Sosin, D. M., Anderson, L., Carande-Kulis, V. G., Teutsch, S. M., et al. (2000) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(99)00122-1 · Cited by 464
Update on adverse drug events associated with parenteral iron
Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmén, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi253 · Cited by 457
Treatment of restless legs syndrome with gabapentin: A double-blind, cross-over study
Garcia-Borreguero, D., Larrosa, O., de la Llave, Y., Verger, K., Masramon, X., & Hernandez, G. (2002) · Neurology · doi:10.1212/wnl.59.10.1573 · Cited by 405
Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
Rabinak, C. A., & Nirenberg, M. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.294 · Cited by 349
The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder
(1999) · Sleep · doi:10.1093/sleep/22.7.970 · Cited by 322
Schenck, C. H., & Mahowald, M. W. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89493-4 · Cited by 291
Practice Parameters for the Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder
Chesson, A. L., Wise, M., Davila, D., Johnson, S., Littner, M., Anderson, W. M., Hartse, K., & Rafecas, J. (1999) · Sleep · doi:10.1093/sleep/22.7.961 · Cited by 287
Walters, A. S., Wagner, M. L., Hening, W. A., Grasing, K., Mills, R., Chokroverty, S., & Kavey, N. (1993) · Sleep · doi:10.1093/sleep/16.4.327 · Cited by 283
Trenkwalder, C., García-Borreguero, D., Montagna, P., Lainey, E., de Weerd, A. W., Tidswell, P., Saletu-Zyhlarz, G. M., Telstad, W., & Ferini‐Strambi, L. (2004) · PubMed · Cited by 283
Hening, W. A., Allen, R. P., Earley, C. J., Picchietti, D. L., & Silber, M. H. (2004) · Sleep · doi:10.1093/sleep/27.3.560 · Cited by 272
Dopamine Dysregulation Syndrome: An Overview of its Epidemiology, Mechanisms and Management
OʼSullivan, S. S., Evans, A. H., & Lees, A. J. (2009) · CNS Drugs · doi:10.2165/00023210-200923020-00005 · Cited by 265
Exercise and Restless Legs Syndrome: A Randomized Controlled Trial
Aukerman, M. M., Aukerman, D., Bayard, M., Tudiver, F., Thorp, L., & Bailey, B. (2006) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.19.5.487 · Cited by 256
L-Dopa Therapy of Uremic and Idiopathic Restless Legs Syndrome: A Double-Blind, Crossover Trial
Trenkwalder, C., Stiasny, K., Pollmächer, T., Wetter, T., Schwarz, J., Kohnen, R., Kazenwadel, J., Krüger, H. P., Ramm, S., Küinzel, M., et al. (1995) · Sleep · doi:10.1093/sleep/18.8.681 · Cited by 253
Restless legs syndrome as side effect of second generation antidepressants
Rottach, K. G., Schaner, B. M., Kirch, M. H., Zivotofsky, A. Z., Teufel, L. M., Gallwitz, T., & Messer, T. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.02.006 · Cited by 249
Walters, A. S., Ondo, W. G., Dreykluft, T., Grunstein, R., Lee, D., Sethi, K., & on behalf of the TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group (2004) · Movement Disorders · doi:10.1002/mds.20257 · Cited by 221
Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)
Winkelman, J. W., & Johnston, L. (2004) · Sleep Medicine · doi:10.1016/j.sleep.2003.07.005 · Cited by 217
Long‐Term follow‐up on restless legs syndrome patients treated with opioids
Walters, A. S., Winkelmann, J., Trenkwalder, C., Fry, J. M., Kataria, V., Wagner, M., Sharma, R., Hening, W., & Li, L. (2001) · Movement Disorders · doi:10.1002/mds.1214 · Cited by 210
Allen, R., Becker, P. M., Bogan, R., Schmidt, M., Kushida, C. A., Fry, J. M., Poceta, J. S., & Winslow, D. (2004) · Sleep · doi:10.1093/sleep/27.5.907 · Cited by 210
Wang, J., O’Reilly, B., Venkataraman, R., Mysliwiec, V., & Mysliwiec, A. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2008.11.003 · Cited by 209
Sloand, J. A., Shelly, M. A., Feigin, A., Bernstein, P., & Monk, R. D. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.11.021 · Cited by 209
Trenkwalder, C., Beneš, H., Poewe, W., Oertel, W. H., Garcia-Borreguero, D., de Weerd, A. W., Ferini-Strambi, L., Montagna, P., Odin, P., Stiasny-Kolster, K., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70112-1 · Cited by 202
Silver, N., Allen, R. P., Senerth, J., & Earley, C. J. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.11.002 · Cited by 197
Efficacy and safety of pramipexole in restless legs syndrome
Winkelman, J. W., Sethi, K. D., Kushida, C. A., Becker, P. M., Koester, J., Cappola, J. J., & Reess, J. (2006) · Neurology · doi:10.1212/01.wnl.0000231513.23919.a1 · Cited by 196
Predictors of impulsivity and reward seeking behavior with dopamine agonists
Ondo, W. G., & Lai, D. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.05.006 · Cited by 195
The treatment of restless legs syndrome with intravenous iron dextran
Earley, C. J., Heckler, D., & Allen, R. P. (2004) · Sleep Medicine · doi:10.1016/j.sleep.2004.03.002 · Cited by 193
Kaplan, P. W., Allen, R. P., Buchholz, D. W., & Walters, J. K. (1993) · Sleep · doi:10.1093/sleep/16.8.717 · Cited by 185
Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists
Tippmann-Peikert, M., Park, J. G., Boeve, B. F., Shepard, J. W., & Silber, M. H. (2007) · Neurology · doi:10.1212/01.wnl.0000252368.25106.b6 · Cited by 172
Treatment of the restless legs syndrome with carbamazepine: a double blind study.
Telstad, W., Sørensen, O., Larsen, S., Lillevold, P. E., Stensrud, P., & Nyberg-Hansen, R. (1984) · BMJ · doi:10.1136/bmj.288.6415.444 · Cited by 170
Gabapentin versus Ropinirole in the Treatment of Idiopathic Restless Legs Syndrome
Happe, S., Sauter, C., Klösch, G., Saletu, B., & Zeitlhofer, J. (2003) · Neuropsychobiology · doi:10.1159/000072882 · Cited by 163
A Randomized, Double-Blind Placebo-Controlled Trial of Iron in Restless Legs Syndrome
Davis, B. J., Rajput, A., Rajput, M. L., Aul, E. A., & Eichhorn, G. R. (2000) · European Neurology · doi:10.1159/000008138 · Cited by 162
Methadone for refractory restless legs syndrome
Ondo, W. G. (2004) · Movement Disorders · doi:10.1002/mds.20359 · Cited by 157
Littner, M. R., Kushida, C. A., Anderson, W. M., Bailey, D. R., Berry, R. B., Hirshkowitz, M., Kapen, S., KRAMER, M. L., Lee-Chiong, T. L., Li, K. K., et al. (2004) · SLEEP · doi:10.1093/sleep/27.3.557 · Cited by 150
Partinen, M., Hirvonen, K., Jama, L., Alakuijala, A., Hublin, C., Tamminen, I., Koester, J., & Reess, J. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.03.011 · Cited by 149
Gambling and Increased Sexual Desire With Dopaminergic Medications in Restless Legs Syndrome
Driver‐Dunckley, E. D., Noble, B. N., Hentz, J. G., Evidente, V. G. H., Caviness, J. N., Parish, J. M., Krahn, L. E., & Adler, C. H. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31804c780e · Cited by 145
Fulda, S., & Wetter, T. C. (2007) · Brain · doi:10.1093/brain/awm244 · Cited by 143
Pramipexole in the Management of Restless Legs Syndrome: An Extended Study
Silber, M. H., Girish, M., & Izurieta, R. (2003) · SLEEP · doi:10.1093/sleep/26.7.819 · Cited by 142
Bogan, R., Fry, J. M., Schmidt, M. H., Carson, S. W., & Ritchie, S. Y. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.1.17 · Cited by 141
Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD)
Saletu, M., Anderer, P., Saletu-Zyhlarz, G. M., Prause, W., Semler, B., Zoghlami, A., Gruber, G., Hauer, C., & Saletu, B. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00080-3 · Cited by 138
Stiasny‐Kolster, K., Kohnen, R., Schollmayer, E., Möller, J. C., Oertel, W. H., & The Rotigotine Sp 666 Study Group (2004) · Movement Disorders · doi:10.1002/mds.20251 · Cited by 137
Earley, C. J., Horská, A., Mohamed, M. A., Barker, P. B., Beard, J. L., & Allen, R. P. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2007.12.006 · Cited by 135
A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients
Thorp, M. L., Morris, C. D., & Bagby, S. P. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.25202 · Cited by 133
Treatment of restless legs syndrome with pregabalin
Garcı́a-Borreguero, D., Larrosa, O., Williams, A., Albares, J. B., Pascual, M., Palacios, J. C., & Fernandez, C. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e1ce73 · Cited by 131
Grote, L., Leissner, L. C., Hedner, J. A., & Ulfberg, J. (2009) · Movement Disorders · doi:10.1002/mds.22562 · Cited by 131
Oertel, W. H., Stiasny‐Kolster, K., Bergtholdt, B., Hallström, Y., Albo, J., Leissner, L. C., Schindler, T. M., Koester, J., & Reess, J. (2006) · Movement Disorders · doi:10.1002/mds.21261 · Cited by 131
Randomized, Double-Blind, Placebo-Controlled Study of Clonidine in Restless Legs Syndrome
Wagner, M., Walters, A. S., Coleman, R., Hening, W., Grasing, K., & Chokroverty, S. (1996) · SLEEP · doi:10.1093/sleep/19.1.52 · Cited by 127
Clonazepam and vibration in restless legs syndrome
Montagna, P., Bianchi, L. S., Zucconi, M., Cirignotta, F., & Lugaresi, E. (1984) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb07826.x · Cited by 125
Sakkas, G. K., Hadjigeorgiou, G. M., Karatzaferi, C., Maridaki, M. D., Giannaki, C. D., Mertens, P. R., Rountas, C. D., Vlychou, M., Liakopoulos, V., & Stefanidis, I. (2008) · ASAIO Journal · doi:10.1097/mat.0b013e3181641b07 · Cited by 124
Pneumatic Compression Devices Are an Effective Therapy for Restless Legs Syndrome
Lettieri, C. J., & Eliasson, A. H. (2008) · CHEST Journal · doi:10.1378/chest.08-1665 · Cited by 120
Valvular heart disease and the use of cabergoline for the treatment of prolactinoma
Herring, N., Szmigielski, C. A., Becher, H. H., Karavitaki, N., & Wass, J. A. H. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03458.x · Cited by 119
Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS
Kushida, C. A., Becker, P. M., Ellenbogen, A. L., Canafax, D. M., Barrett, R. W., & The XP052 Study Group (2009) · Neurology · doi:10.1212/01.wnl.0000341770.91926.cc · Cited by 115
Dopamine agonists and cardiac valvulopathy in Parkinson disease: A case–control study
Yamamoto, M., Uesugi, T., & Nakayama, T. (2006) · Neurology · doi:10.1212/01.wnl.0000238508.68593.1d · Cited by 113
Efficacy of pergolide in treatment of restless legs syndrome
Trenkwalder, C., Hundemer, H., Lledó, A., Swieca, J., Polo, O. J., Wetter, T. C., Ferini‐Strambi, L., de Groen, H., Quail, D., & Brandenburg, U. (2004) · Neurology · doi:10.1212/01.wnl.0000124465.20878.84 · Cited by 113
Hening, W. A., Allen, R. P., Ondo, W. G., Walters, A. S., Winkelman, J. W., Becker, P. M., Bogan, R., Fry, J. M., Kudrow, D., Lesh, K. W., et al. (2010) · Movement Disorders · doi:10.1002/mds.23157 · Cited by 112
Lee, D. O., Ziman, R. B., Perkins, A. T., Poceta, J. S., Walters, A. S., Barrett, R. W., & XP053 Study Group (2011) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.1074 · Cited by 109
Oertel, W. H., Beneš, H., Garcı́a-Borreguero, D., Geisler, P., Högl, B., Saletu, B., Trenkwalder, C., Sommerville, K. W., Schollmayer, E., Kohnen, R., et al. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.04.010 · Cited by 109
Effective cabergoline treatment in idiopathic restless legs syndrome
Stiasny‐Kolster, K., Beneš, H., Peglau, I., Hornyak, M., Holinka, B., Wessel, K., Emser, W., Leroux, M., Kohnen, R., & Oertel, W. H. (2004) · Neurology · doi:10.1212/01.wnl.0000147297.51023.c8 · Cited by 108
Högl, B., Garcı́a-Borreguero, D., Kohnen, R., Ferini‐Strambi, L., Hadjigeorgiou, G. M., Hornyak, M., de Weerd, A., Happe, S., Stiasny‐Kolster, K., Gschliesser, V., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5299-8 · Cited by 107
Ropinirole for restless legs syndrome
Adler, C. H., Hauser, R. A., Sethi, K. D., Caviness, J. N., Marlor, L., Anderson, W. M., & Hentz, J. G. (2004) · Neurology · doi:10.1212/01.wnl.0000120672.94060.f1 · Cited by 107
Trenkwalder, C., Beneš, H., Grote, L., Happe, S., Högl, B., Mathis, J., Saletu-Zyhlarz, G. M., Kohnen, R., & CALDIR study group (2007) · Movement Disorders · doi:10.1002/mds.21401 · Cited by 106
Allen, R. P., Chen, C., Soaita, A., Wohlberg, C. J., Knapp, L. E., Peterson, B. T., García-Borreguero, D., & Miceli, J. J. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.03.003 · Cited by 103
Mıcozkadıoğlu, H., Özdemir, F. N., Kut, A., Sezer, S., Saatçi, U., & Haberal, M. A. (2004) · Renal Failure · doi:10.1081/jdi-120039823 · Cited by 102
The Treatment of the Restless Legs Syndrome with Clonazepam: A Prospective Controlled Study
Boghen, D., Lamothe, L., Elie, R., Godbout, R., & Montplaisir, J. Y. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100036350 · Cited by 99
Montplaisir, J. Y., Karrasch, J., Haan, J., & Volc, D. (2006) · Movement Disorders · doi:10.1002/mds.21050 · Cited by 97
Ferini‐Strambi, L., Aarskog, D., Partinen, M., Chaudhuri, К. R., Sohr, M., Verri, D., & Albrecht, S. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2008.09.001 · Cited by 97
Treatment of Restless Legs Syndrome With Tramadol
Lauerma, H., & Markkula, J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0407 · Cited by 95
Oertel, W. H., Beneš, H., Garcı́a-Borreguero, D., Högl, B., Poewe, W. H., Montagna, P., Ferini‐Strambi, L., Sixel‐Döring, F., Trenkwalder, C., Partinen, M., et al. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.02.014 · Cited by 95
Bliwise, D. L., Freeman, A. A. H., Ingram, C. D., Rye, D. B., Chakravorty, S., & Watts, R. L. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2004.12.002 · Cited by 94
Ropinirole as a Treatment of Restless Legs Syndrome in Patients on Chronic Hemodialysis
Pellecchia, M. T., Vitale, C., Sabatini, M., Longo, K., Amboni, M., Bonavita, V., & Barone, P. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000135480.78529.06 · Cited by 94
Antidepressant medication use and restless legs syndrome in patients presenting with insomnia
Brown, L. K., Dedrick, D. L., Doggett, J. W., & Guido, P. S. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2005.03.005 · Cited by 93
L-DOPA/Carbidopa for Nocturnal Movement Disorders in Uremia
Walker, S. L., Fine, A., & Kryger, M. H. (1996) · SLEEP · doi:10.1093/sleep/19.3.214 · Cited by 91
Eisensehr, I., Ehrenberg, B. L., Solti, S. R., & Noachtar, S. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0367-6 · Cited by 89
Augmentation of restless legs syndrome with long‐term tramadol treatment
Vetrugno, R., Morgia, C. L., D’Angelo, R., Loi, D., Provini, F., Plazzi, G., & Montagna, P. (2007) · Movement Disorders · doi:10.1002/mds.21342 · Cited by 88
Trenkwalder, C., Stiasny‐Kolster, K., Kupsch, A. R., Oertel, W. H., Koester, J., & Reess, J. (2006) · Movement Disorders · doi:10.1002/mds.20983 · Cited by 85
Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome
Winkelman, J. W., Bogan, R., Schmidt, M. H., Hudson, J. D., DeRossett, S. E., & Hill‐Zabala, C. E. (2011) · Movement Disorders · doi:10.1002/mds.23771 · Cited by 81
Pathological gambling associated with dopamine agonist use in restless legs syndrome
Quickfall, J., & Suchowersky, O. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.10.001 · Cited by 76
Saletu, M., Anderer, P., Saletu-Zyhlarz, G. M., Hauer, C., & Saletu, B. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-002-0380-7 · Cited by 75
Cardiac and noncardiac fibrotic reactions caused by ergot‐and nonergot‐derived dopamine agonists
Andersohn, F., & Garbe, E. (2008) · Movement Disorders · doi:10.1002/mds.22385 · Cited by 75
Bogan, R., Bornemann, M. A. C., Kushida, C. A., Trân, P. V., & Barrett, R. W. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0700 · Cited by 73
Kushida, C. A., Walters, A. S., Becker, P. M., Thein, S., Perkins, A. T., Roth, T. G., Canafax, D. M., Barrett, R. W., & The XP021 Study Group (2009) · SLEEP · doi:10.1093/sleep/32.2.159 · Cited by 72
García-Borreguero, D., Grunstein, R. R., Sridhar, G., Dreykluft, T., Montagna, P., Dom, R., Lainey, E., Moorat, A., & Roberts, J. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.09.009 · Cited by 72
Hornyak, M., Grossmann, C., Kohnen, R., Schlatterer, M., Richter, H., Voderholzer, U., Riemann, D., & Berger, M. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.138867 · Cited by 71
Pregabalin in restless legs syndrome with and without neuropathic pain
Sommer, M., Bachmann, C. G., Liebetanz, K. M., Schindehütte, J., Tings, T., & Paulus, W. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00796.x · Cited by 69
Intravenous iron dextran for severe refractory restless legs syndrome
Ondo, W. G. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2009.12.002 · Cited by 68
Efficacy of cabergoline in restless legs syndrome
Oertel, W. H., Beneš, H., Bodenschatz, R., Peglau, I., Warmuth, R., Happe, S., Geisler, P., Cassel, W., Leroux, M., Kohnen, R., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000237742.08297.22 · Cited by 68
Nocturnal myoclonus in restless legs syndrome effect of carbamazepine treatment.
Zucconi, M., Coccagna, G., Petronelli, R., Gerardi, R., Mondini, S., & Cirignotta, F. (1989) · PubMed · Cited by 68
Trenkwalder, C., Collado-Seidel, V., Kazenwadel, J., Wetter, T. C., Oertel, W. H., Selzer, R., & Kohnen, R. (2003) · Movement Disorders · doi:10.1002/mds.10503 · Cited by 67
Saletu, M., Anderer, P., H�gl, B., Saletu-Zyhlarz, G. M., Kunz, A. B., Poewe, W. H., & Saletu, B. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0814-z · Cited by 66
Gabapentin Enacarbil in Restless Legs Syndrome
Walters, A. S., Ondo, W. G., Kushida, C. A., Becker, P. M., Ellenbogen, A. L., Canafax, D. M., & Barrett, R. W. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181b3ab16 · Cited by 66
Beneš, H., Heinrich, C. R., Ueberall, M. A., & Kohnen, R. (2004) · SLEEP · doi:10.1093/sleep/27.4.674 · Cited by 66
Carbamazepine in restless legs
Lundvall, O., �bom, P. E., & Holm, R. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf01037942 · Cited by 66
Clonazepam: effective treatment for restless legs syndrome in uraemia.
Read, D. J., Feest, T., & Nassim, M. A. (1981) · BMJ · doi:10.1136/bmj.283.6296.885-a · Cited by 65
Exogenous Melatonin in Periodic Limb Movement Disorder: An Open Clinical Trial and a Hypothesis
Kunz, D., & Bes, F. (2001) · SLEEP · doi:10.1093/sleep/24.2.183 · Cited by 64
Leutgeb, U., & Martus, P. (2002) · PubMed · Cited by 61
Tan, T., Cabrita, I. Z., Moss, D. J. H., Grogono, J. C., Dhillo, W. S., Baynes, K., Eliahoo, J., Meeran, K. M., Robinson, S., Nihoyannopoulos, P., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03827.x · Cited by 59
Simonis, G., Fuhrmann, J. T., & Strasser, R. H. (2007) · Movement Disorders · doi:10.1002/mds.21639 · Cited by 57
Nachtigall, L. B., Valassi, E., Lo, J., McCarty, D., Passeri, J. J., Biller, B. M. K., Miller, K. K., Utz, A. L., Grinspoon, S. K., Lawson, E. A., et al. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03608.x · Cited by 55
Oertel, W. H., Beneš, H., Garcı́a-Borreguero, D., Geisler, P., Högl, B., Trenkwalder, C., Tacken, I., Schollmayer, E., Kohnen, R., & Stiasny‐Kolster, K. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2008.04.012 · Cited by 55
L-Dopa in Uremic Patients with the Restless Legs Syndrome
Sandyk, R., Bernick, C. B., Lee, S. M., Stern, L. Z., Iacono, R. P., & Bamford, C. R. (1987) · International Journal of Neuroscience · doi:10.3109/00207458708987132 · Cited by 54
Valproate for Sleep Consolidation in Periodic Limb Movement Disorder
Ehrenberg, B. L., Eisensehr, I., Corbett, K., Crowley, P. F., & Walters, A. S. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200010000-00013 · Cited by 53
Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis
Evans, A. H., & Butzkueven, H. (2007) · Movement Disorders · doi:10.1002/mds.21303 · Cited by 52
Restless legs syndrome treated successfully by kidney transplantation--a case report.
Yasuda, T., Nishimura, A., Katsuki, Y., & Tsuji, Y. (1986) · PubMed · Cited by 52
Amantadine is beneficial in restless legs syndrome
Evidente, V. G. H., Adler, C. H., Caviness, J. N., Hentz, J. G., & Gwinn, K. A. (2000) · Movement Disorders · Cited by 51
Montagna, P., Hornyak, M., Ulfberg, J., Hong, S. B., Koester, J., Crespi, G., & Albrecht, S. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.08.005 · Cited by 50
Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis
Miranda, M., Kägi, M., Fabres, L., Aguilera, L., Alvo, M., Leticia Elgueta, S., Erazo, S. S., & Venegas, P. (2004) · Neurology · doi:10.1212/01.wnl.0000113752.14744.15 · Cited by 49
A 52-Week Study of Gabapentin Enacarbil in Restless Legs Syndrome
Ellenbogen, A. L., Thein, S., Winslow, D. H., Becker, P. M., Tolson, J. M., Lassauzet, M.-L., & Chen, D. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182087d48 · Cited by 48
Jama, L., Hirvonen, K., Partinen, M., Alakuijala, A., Hublin, C., Tamminen, I., Koester, J., & Reess, J. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2008.05.014 · Cited by 46
The Effect of Sclerotherapy on Restless Legs Syndrome
KANTER, A. (1995) · Dermatologic Surgery · doi:10.1111/j.1524-4725.1995.tb00183.x · Cited by 41
Högl, B., Oertel, W. H., Stiasny‐Kolster, K., Geisler, P., Beneš, H., Garcı́a-Borreguero, D., Trenkwalder, C., Poewe, W. H., Schollmayer, E., & Kohnen, R. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-86 · Cited by 40
Sequential Compression Devices for Treatment of Restless Legs Syndrome
Eliasson, A. H., & Lettieri, C. J. (2007) · Medicine · doi:10.1097/md.0b013e31815b1319 · Cited by 40
Beneš, H. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2005.05.007 · Cited by 40
Low-Dose Pramipexole in the Management of Restless Legs Syndrome
Stiasny‐Kolster, K., & Oertel, W. H. (2004) · Neuropsychobiology · doi:10.1159/000077943 · Cited by 39
Inoue, Y., Hirata, K., Kuroda, K., Fujita, M., Shimizu, T., Emura, N., Uchimura, N., Kagimura, T., Sha, K., & Nozawa, T. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2009.03.009 · Cited by 39
Zucconi, M., Oldani, A., Castronovo, C., & Ferini‐Strambi, L. (2003) · SLEEP · doi:10.1093/sleep/26.7.815 · Cited by 39
Gender differences in the association between antidepressant use and restless legs syndrome
Baughman, K. R., Bourguet, C. C., & Ober, S. K. (2009) · Movement Disorders · doi:10.1002/mds.22517 · Cited by 38
[Successful clonidine treatment of restless leg syndrome in chronic kidney insufficiency].
Ausserwinkler, M., & Schmidt, P. (1989) · PubMed · Cited by 38
Giannaki, C. D., Sakkas, G. K., Hadjigeorgiou, G. M., Karatzaferi, C., Patramani, G., Lavdas, E., Liakopoulos, V., Koutedakis, Y., & Stefanidis, I. (2010) · ASAIO Journal · doi:10.1097/mat.0b013e3181f1cc04 · Cited by 37
The effect of endovenous laser ablation on restless legs syndrome
Hayes, C. A., Kingsley, J. R., Hamby, K. R., & CARLOW, J. J. (2008) · Phlebology The Journal of Venous Disease · doi:10.1258/phleb.2007.007051 · Cited by 37
Partinen, M., Hirvonen, K., Jama, L., Alakuijala, A., Hublin, C., Tamminen, I., Koester, J., & Reess, J. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2007.12.004 · Cited by 36
Factors potentiating the risk of mirtazapine‐associated restless legs syndrome
Kim, S., Shin, I., Kim, J., Park, K. D., Youn, T., & Yoon, J. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.965 · Cited by 35
Long-term open-label study of pramipexole in patients with primary restless legs syndrome
Inoue, Y., Kuroda, K., Hirata, K., Uchimura, N., Kagimura, T., & Shimizu, T. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.04.003 · Cited by 35
Treatment of periodic limb movements in sleep with selegiline HCl
Grewal, M., Hawa, R., & Shapiro, C. M. (2002) · Movement Disorders · doi:10.1002/mds.10082 · Cited by 33
Piribedil for restless legs syndrome: A pilot study
Evidente, V. G. H. (2001) · Movement Disorders · doi:10.1002/mds.1104 · Cited by 32
Hornyak, M., Sohr, M., & Busse, M. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.11.007 · Cited by 31
Poor effect of guideline based treatment of restless legs syndrome in clinical practice
Godau, J., Spinnler, N., Wevers, A.-K., Trenkwalder, C., & Berg, D. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.211417 · Cited by 30
Dopamine dysregulation syndrome in a patient with restless legs syndrome
Leu‐Semenescu, S., Karroum, E. G., Brion, A., Konofal, É., & Arnulf, I. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2008.12.010 · Cited by 28
Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?
Cuellar, N. G., & Ratcliffe, S. J. (2009) · PubMed · Cited by 26
Assessment of the Symptomatic Benefit of Cool Dialysate
Kerr, P. G., van Bakel, C., & Dawborn, J. K. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000185622 · Cited by 25
On the Goodness of Recommendations: The Changing Face of Practice Parameters
Aurora, R. N., & Morgenthaler, T. I. (2010) · SLEEP · doi:10.1093/sleep/33.10.1273 · Cited by 20
Self-citationBeneš, H., Deissler, A., Rodenbeck, A., Engfer, A., & Kohnen, R. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0386-1 · Cited by 20
Kushida, C. A., Geyer, J. D., Tolson, J. M., et al. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31815a3eec · Cited by 19
Inoue, Y., Kuroda, K., Hirata, K., Uchimura, N., Kagimura, T., & Shimizu, T. (2010) · Neuropsychobiology · doi:10.1159/000322289 · Cited by 19
Giorgi, L., Ritchie, S. Y., & Kirsch, J. M. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x132442 · Cited by 14
Entacapone Prolongs the Reduction of PLM by Levodopa/Carbidopa in Restless Legs Syndrome
Polo, O. J., Ylä-Sahra, R., Hirvonen, K., Karvinen, J., Vahteristo, M., & Ellmén, J. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31805930c2 · Cited by 11
Cited by
Allen, R. P., Picchietti, D. L., Garcia-Borreguero, D., Ondo, W. G., Walters, A. S., Winkelman, J. W., Zucconi, M., Ferri, R., Trenkwalder, C., & Lee, H. B. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.03.025 · Cited by 1,609
Allen, R. P., Picchietti, D. L., Auerbach, M., Cho, Y. W., Connor, J. R., Earley, C. J., Garcia-Borreguero, D., Kotagal, S., Manconi, M., Ondo, W., et al. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2017.11.1126 · Cited by 349
Migraine and sleep disorders: a systematic review
Tiseo, C., Vacca, A., Felbush, A., Filimonova, T., Gai, A., Glazyrina, T., Hubalek, I. A., Marchenko, Y., Overeem, L. H., Piroso, S., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01192-5 · Cited by 288
Schipper, S. B. J., Van Veen, M. M., Elders, P. J. M., van Straten, A., Van Der Werf, Y. D., Knutson, K. L., & Rutters, F. (2021) · Diabetologia · doi:10.1007/s00125-021-05541-0 · Cited by 202
Addressing sleep disturbances: an opportunity to prevent cardiometabolic disease?
Grandner, M. A. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2014.911148 · Cited by 88
“Conceptualizing sleep disturbance in the context of public health Although most, if not all, sleep disorders have targeted interventions (e.g. PAP therapies for sleep apnoea (Avlonitou et al., 2012; Bertisch & Patel, 2012; Campbell et al., 2012; Ciccone et al., 2012; Filtness et al., 2012; Hegglin et al., 2012; Zhao e…”
Metadata
- Authors
- Aurora, R. N., Kristo, D. A., Bista, S. R., Rowley, J. A., Zak, R. S., Casey, K. R., Lamm, C. I., Tracy, S. L., & Rosenberg, R. S.
- Venue
- SLEEP
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-01
- Volume
- 35
- Issue
- 8
- Pages
- 1039-62
- ISSN
- 0161-8105 (ISSN-L)
- 1550-9109
- OpenAlex
- W222867287
- Cited by
- 303
- References
- 143
- FWCI
- 22.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.